Effect of Euterpe oleracea Mart. (Açaí) Oil on Dyslipidemia Caused by Cocos nucifera L. Saturated Fat in Wistar Rats

• Published in: Journal of medicinal food Vol. 20; no. 9; p. 830
• Main Authors: Faria E Souza, Belmira S, Carvalho, Helison O, Taglialegna, Talisson, Barros, Albenise Santana A, da Cunha, Edilson Leal, Ferreira, Irlon Maciel, Keita, Hady, Navarrete, Andres, Carvalho, José Carlos Tavares
• Format: Journal Article
• Language: English
• Published: United States 01-09-2017
• Subjects: Animals; Aorta, Thoracic - metabolism; Cholesterol - blood; Cholesterol, LDL - blood; Cocos - adverse effects; Cocos - chemistry; Dyslipidemias - diet therapy; Dyslipidemias - etiology; Dyslipidemias - metabolism; Euterpe - chemistry; Fatty Acids - adverse effects; Fatty Acids - metabolism; Fruit - chemistry; Fruit - metabolism; Humans; Male; Plant Oils - metabolism; Rats; Rats, Wistar; Triglycerides - blood; atherosclerosis; oil; fatty acids; dyslipidemia; Euterpe oleracea Mart; Açai; Cocos nucifera L
• ISSN: 1557-7600
• DOI: 10.1089/jmf.2017.0027

Dyslipidemia is caused by disturbances in lipid metabolism that lead to chronic elevations of serum lipids, especially low-density lipoprotein (LDL)-cholesterol and triglycerides, increasing the risk of metabolic syndrome, obesity, diabetes, atherogenic processes, and cardiovascular diseases. The oil from the fruits of Euterpe oleracea (OFEO) is rich in unsaturated fatty acids with potential for treating alterations in lipid metabolism. In this study, we aimed to investigate the effect of OFEO on hyperlipidemia induced by Cocos nucifera L. saturated fat (GSC) in Wistar rats. Chromatographic profile showed that unsaturated fatty acids account for 66.08% in OFEO, predominately oleic acid (54.30%), and saturated fatty acids (palmitic acid 31.6%) account for 33.92%. GSC-induced dyslipidemia resulted in an increase in total cholesterol, LDL-cholesterol, triglycerides, glucose, and liver and abdominal fat, as well as atherogenic processes in the thoracic aorta. OFEO treatment did not reduce hypertriglyceridemia, but did reduce total cholesterol and LDL-cholesterol, thus contributing to the antiatherogenic action of OFEO. OFEO treatment inhibited the formation of atheromatous plaques in the vascular endothelium of the treated rats, as well as those who were treated with simvastatin. The results obtained suggest that OFEO has an antiatherogenic effect in a rat model of dyslipidemia.